ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
Dow Jones
39,069.59
0.01%
Brent Oil
82.155
0.21%
Bitcoin
68,775.62
0.39%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Amryt Pharma PLC (AMYT)

  7. Amryt Pharma PLC (AMYT) News

AMYT

Amryt Pharma (AMYT)

Amryt Pharma PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AMYT
DateTimeSourceHeadlineSymbolCompany
04/18/20235:02PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AMYTAmryt Pharma PLC
04/18/20235:01PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AMYTAmryt Pharma PLC
04/18/20234:16PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
04/12/20235:29PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
04/12/20238:21AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AMYTAmryt Pharma PLC
04/12/20237:58AMPR Newswire (US)Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma PlcNASDAQ:AMYTAmryt Pharma PLC
04/12/20237:00AMGlobeNewswire Inc.Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma PlcNASDAQ:AMYTAmryt Pharma PLC
04/11/20239:00AMGlobeNewswire Inc.2022 for Chiesi: The Group’s international growth continuesNASDAQ:AMYTAmryt Pharma PLC
04/03/20239:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
03/23/20239:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
02/16/20237:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
02/13/202310:25AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
02/10/20234:02PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
02/10/20239:49AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMYTAmryt Pharma PLC
01/09/20234:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
11/06/202210:35PMTipRanksSVB Securities Keeps Their Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
11/04/20222:55PMTipRanksAmryt Pharma (AMYT) Receives a Buy from Maxim GroupNASDAQ:AMYTAmryt Pharma PLC
11/04/20226:25AMTipRanksAmryt Pharma (AMYT) Receives a Buy from H.C. WainwrightNASDAQ:AMYTAmryt Pharma PLC
11/03/20227:45AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
09/19/20226:25AMTipRanksH.C. Wainwright Sticks to Its Buy Rating for Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
08/08/20228:27AMTipRanksH.C. Wainwright Keeps Their Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
08/05/20221:25PMTipRanksMaxim Group Reiterates a Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
07/14/20227:49AMDow Jones NewsAmryt Gets FDA Orphan Designation for Mycapssa in Carcinoid SyndromeNASDAQ:AMYTAmryt Pharma PLC
06/26/20223:39AMTipRanksSVB Securities Keeps a Buy Rating on Amryt Pharma (AMYT)NASDAQ:AMYTAmryt Pharma PLC
06/24/20227:54AMDow Jones NewsAmryt to Pursue Formal FDA Resolution for Oleogel-S10NASDAQ:AMYTAmryt Pharma PLC
06/24/20227:19AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
06/23/20227:26AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AMYTAmryt Pharma PLC
05/23/20226:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AMYTAmryt Pharma PLC
05/20/20225:07PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:AMYTAmryt Pharma PLC
05/20/20224:59PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:AMYTAmryt Pharma PLC
 Showing the most relevant articles for your search:NASDAQ:AMYT

Your Recent History

BIT
I06288
Banca Imi
BIT
P1HL75
BNP Paribas Issuance
BOV
FAED11
FundoInvest Imobiliario ...
BIT
P122M2
BNP PARIBAS ISSUANCE
BIT
I05675
Banca IMI
BIT
FCT
Fincantieri
BIT
REY
Reply
BIT
I08664
Intesa Sanpaolo
BIT
L82999
Credit Agricole Corporat...
LSE
ON19
Cred Ag Co 29
BIT
F28903
Vontobel Financial Produ...
BIT
P17RJ2
BNP Paribas Issuance
BIT
P15BR3
BNP Paribas Issuance
BIT
I05059
Banca IMI
BIT
P118W9
Bnp Paribas Issuance
USOTC
XOEFD
X1 Entertainment (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved